Scientech Research LLC’s Arcellx ACLX Stock Holding History

Scientech Research LLC’s Portfolio ACLX Stock Details ACLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-10,281	Closed	-$788K	–	546
2024 Q4	$788K	Buy	+10,281	New	+$888K	0.22%	171

Other funds holding ACLX

Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

VPC

Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return

SOCM

SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return

Scientech Research LLC's ACLX Position: Q1 2025 in Review

Scientech Research LLC sold out of Arcellx (ACLX) in Q1 2025, closing a stake of 10,281 shares — an estimated $788K sold.

Scientech Research LLC first reported a position in ACLX in Q4 2024 and held it in 1 quarter. The position peaked at $788K in Q4 2024. 197 funds tracked by Wall St. Rank hold ACLX as of Q1 2025.

Scientech Research LLC reported no remaining Arcellx position as of Q1 2025 after selling out during the quarter.
Scientech Research LLC sold 10,281 Arcellx shares in Q1 2025, an estimated $788K.
Scientech Research LLC first reported a position in Arcellx in Q4 2024 and held it in 1 quarter.
Scientech Research LLC's Arcellx position peaked at $788K in Q4 2024.
197 funds tracked by Wall St. Rank held Arcellx as of Q1 2025.

Based on Scientech Research LLC's 13F filing for Q1 2025, filed 15 May 2025.